Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReSound is a global leader in the hearing aid industry, specializing in advanced audiological solutions and smart hearing technology. As a key brand within the GN Group, the company develops innovative hearing instruments that integrate seamlessly with digital devices, offering features like direct streaming and remote fine-tuning. Their product portfolio, including the ReSound Nexia and OMNIA series, utilizes sophisticated signal processing to improve speech understanding in complex acoustic environments. ReSound is recognized for pioneering the first Made for iPhone hearing aid and continues to drive the industry forward with Bluetooth Low Energy and Auracast integrations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReSound.